Showing 36,741 - 36,760 results of 66,452 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (mean decrease)) ))', query time: 1.42s Refine Results
  1. 36741

    FRAP analysis reveals PFN1 as major regulator of actin dynamics in astrocytic processes. by Stefanie K. Schweinhuber (687289)

    Published 2015
    “…Significance is indicated as follows *p<0.05; **p<0.01; ***p<0.001. Data are shown as mean ± SEM.…”
  2. 36742

    Molecular mechanisms of impaired intestinal barrier function. by Tim Vanuytsel (513970)

    Published 2014
    “…(E) Western Blot analysis at 50 days shows decreased CLDN1 expression and a tendency towards increased CLDN2 expression (P = 0.07) in BB-DP rats (white bars) compared to controls (black bars). …”
  3. 36743

    Table1_Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats.DOCX by Min Zhou (173135)

    Published 2022
    “…Storax treatment of 0.2, 0.4, and 0.8 g/kg led to a significant decrease in infarction size, and the Storax 0.4, 0.8 g/kg groups displayed a significant reduction in brain water content. …”
  4. 36744
  5. 36745
  6. 36746
  7. 36747
  8. 36748
  9. 36749
  10. 36750
  11. 36751
  12. 36752
  13. 36753
  14. 36754
  15. 36755
  16. 36756

    Results linear mixed model on factors predicting change in saturation, heart frequency, systolic and diastolic blood pressure. by Edwin J. van Adrichem (830745)

    Published 2015
    “…Example: saturation is expected to be 9.7% less at an altitude of 4680 meters and, with every year that someone is older a decrease in saturation of 0.1% is expected.</p><p>Results linear mixed model on factors predicting change in saturation, heart frequency, systolic and diastolic blood pressure.…”
  17. 36757

    DataSheet_1_Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.docx by Patricia T. Illing (6746918)

    Published 2021
    “…<p>Abacavir hypersensitivity syndrome can occur in individuals expressing the HLA-B*57:01 major histocompatibility complex class I allotype when utilising the drug abacavir as a part of their anti-retroviral regimen. …”
  18. 36758

    Table_1_Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.xlsx by Patricia T. Illing (6746918)

    Published 2021
    “…<p>Abacavir hypersensitivity syndrome can occur in individuals expressing the HLA-B*57:01 major histocompatibility complex class I allotype when utilising the drug abacavir as a part of their anti-retroviral regimen. …”
  19. 36759

    Serum cytokine levels at B-cell-related time points by Therese Vallerskog (24325)

    Published 2011
    “…In APRIL, a significant decrease (< 0.05) occurred at depletion compared with baseline. …”
  20. 36760

    DEVDase (caspase 3-like) activity in the brain of PQ-exposed <i>Drosophila</i>. by Arvind Kumar Shukla (519573)

    Published 2014
    “…Significance ascribed as **<i>p</i><0.01 and ***<i>p</i><0.001 vs. control; <b><sup>$</sup></b><i>p</i><0.05; <b><sup>$$</sup></b><i>p</i><0.01 and <b><sup>$$$</sup></b><i>p</i><0.001 vs. …”